N
ABMD

Nuveen’s Abiomed Inc ABMD Stock Holding History

Nuveen’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-197,202
Closed -$48.4M – 3293
2022
Q3 		$48.4M Sell
197,202
-885
-0.4% -$239K 0.02% 536
2022
Q2 		$49M Buy
198,087
+4,369
+2% +$1.18M 0.02% 563
2022
Q1 		$59.4M Sell
193,718
-25,605
-12% -$7.88M 0.02% 569
2021
Q4 		$78.8M Sell
219,323
-4,959
-2% -$1.68M 0.02% 500
2021
Q3 		$73M Sell
224,282
-48,302
-18% -$16.4M 0.02% 535
2021
Q2 		$85.1M Buy
272,584
+3,695
+1% +$1.13M 0.03% 522
2021
Q1 		$85.7M Sell
268,889
-6,723
-2% -$2.15M 0.03% 507
2020
Q4 		$89.4M Buy
275,612
+59,978
+28% +$16.6M 0.03% 462
2020
Q3 		$59.7M Buy
215,634
+5,812
+3% +$1.67M 0.02% 520
2020
Q2 		$50.7M Buy
209,822
+21,797
+12% +$4.38M 0.02% 542
2020
Q1 		$27.3M Buy
188,025
+28,572
+18% +$4.74M 0.01% 733
2019
Q4 		$27.2M Buy
159,453
+1,767
+1% +$328K 0.01% 993
2019
Q3 		$28.1M Sell
157,686
-40,073
-20% -$8.66M 0.01% 954
2019
Q2 		$51.5M Buy
197,759
+196,657
+17,845% +$52.2M 0.02% 671
2019
Q1 		$315K Buy
1,102
+27
+3% +$8.97K ﹤0.01% 924
2018
Q4 		$349K Buy
1,075
+25
+2% +$8.68K ﹤0.01% 867
2018
Q3 		$472K Buy
1,050
+127
+14% +$50.1K ﹤0.01% 873
2018
Q2 		$378K Buy
+923
New +$334K ﹤0.01% 916
2017
Q4 		– Sell
-43,159
Closed -$7.28M – 1168
2017
Q3 		$7.28M Sell
43,159
-30,567
-41% -$4.62M 0.05% 444
2017
Q2 		$10.6M Sell
73,726
-2,336
-3% -$314K 0.07% 396
2017
Q1 		$9.52M Buy
76,062
+64,793
+575% +$7.51M 0.06% 430
2016
Q4 		$1.27M Sell
11,269
-85,497
-88% -$9.9M 0.01% 1066
2016
Q3 		$12.4M Sell
96,766
-14,788
-13% -$1.77M 0.07% 328
2016
Q2 		$12.2M Sell
111,554
-24,466
-18% -$2.43M 0.07% 320
2016
Q1 		$12.9K Sell
136,020
-63,689
-32% -$5.38M 0.07% 291
2015
Q4 		$18K Buy
199,709
+18,847
+10% +$1.6M 0.09% 234
2015
Q3 		$16.8K Sell
180,862
-66,318
-27% -$5.84M 0.1% 258
2015
Q2 		$16.2K Sell
247,180
-25,319
-9% -$1.68M 0.09% 281
2015
Q1 		$19.5M Sell
272,499
-15,283
-5% -$830K 0.11% 263
2014
Q4 		$11M Buy
+287,782
New +$9.08M 0.06% 372

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nuveen's ABMD Position: Q4 2022 in Review

Nuveen sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 197,202 shares — an estimated $48.4M sold.

Nuveen first reported a position in ABMD in Q4 2014 and held it in 30 quarters. The position peaked at $89.4M in Q4 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Nuveen reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Nuveen sold 197,202 Abiomed Inc shares in Q4 2022, an estimated $48.4M.
  • Nuveen first reported a position in Abiomed Inc in Q4 2014 and held it in 30 quarters.
  • Nuveen's Abiomed Inc position peaked at $89.4M in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.